Search - Université Clermont Auvergne Access content directly

Filter your results

34 Results
Structure: Internal structure identifier : 179570
Image document

Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway

Cédric Chaveroux , Carmen Sarcinelli , Virginie Barbet , Sofiane Belfeki , Audray Barthelaix et al.
Scientific Reports, 2016, 6 (1), ⟨10.1038/srep27278⟩
Journal articles hal-01595359v1

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Lionel Adès , Xavier Thomas , Agnes Cuerci-Bres , Raffoux Emmanuel , Olivier Spertini et al.
Blood, 2015, 126 (23), pp.451
Journal articles hal-01300812v1

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

D. Dano , A. Lardy-Cleaud , A. Monneur , N. Quenel-Tueux , C. Levy et al.
ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩
Journal articles hal-03426433v1

Quelle vision des biomarqueurs en 2017 ? Promesses et défis de la médecine personnalisée en oncologie

Ronan Flippot , Christophe Massard , Édouard Auclin , David Azria , Heloise Bourien et al.
Bulletin du Cancer, 2017, 104 (9), pp.735-743. ⟨10.1016/j.bulcan.2017.07.003⟩
Journal articles hal-02370054v1

Les points chauds de l’actualité en 2017. Une sélection du comité de rédaction du Bulletin du Cancer

Stéphane Vignot , Thierry André , Christophe Caux , Carole Bouleuc , Serge Evrard et al.
Bulletin du Cancer, 2018, 105 (1), pp.6 - 14. ⟨10.1016/j.bulcan.2017.11.006⟩
Journal articles hal-01712424v1

[2021 update of the GEFPICS’ recommendations for HER2 status assessment in invasive breast cancer in France]

Camille Franchet , Lounes Djerroudi , Aurélie Maran-Gonzalez , Olivia Abramovici , Martine Antoine et al.
Annales de Pathologie, 2021, ⟨10.1016/j.annpat.2021.07.014⟩
Journal articles hal-03333764v1
Image document

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption

Chloé Terciolo , Michel Dapoigny , Frédéric André
Clinical and Experimental Gastroenterology, 2019, Volume 12, pp.67-82. ⟨10.2147/CEG.S181590⟩
Journal articles hal-02533345v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

Perception of pharmacy students toward opioid-related disorders and roles of community pharmacists: A French nationwide cross-sectional study

David Balayssac , Bruno Pereira , Pierre Cuq , Juliette Douris , Luc Ferrari et al.
Substance Abuse, 2021, 42 (4), pp.706-715. ⟨10.1080/08897077.2020.1850607⟩
Journal articles hal-03077594v1

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting―IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms

Michèle Beau-Faller , Hélène Blons , Caroline Domerg , Dorota Gajda , Nicolas Richard et al.
Journal of Molecular Diagnostics, 2014, 16 (1), pp.45--55. ⟨10.1016/j.jmoldx.2013.07.009⟩
Journal articles hal-01064291v1

Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis

Julie Quilliot , Marion Couderc , Charlotte Giraud , Martin Soubrier , Sylvain Mathieu et al.
Annals of Surgical Oncology, 2019, 26 (2), pp.356-365. ⟨10.1245/s10434-018-6831-9⟩
Journal articles hal-02343522v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03441014v1

Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial

Arnaud Pigneux , Marie Béné , Louis-Rachid Salmi , Pierre-Yves Dumas , Jacques Delaunay et al.
Journal of Clinical Oncology, 2018, 36 (32), pp.3203-3210. ⟨10.1200/JCO.2018.78.7366⟩
Journal articles hal-02874606v1
Image document

Greffe de cellules souches hématopoïétiques haplo-identiques avec cyclophosphamide en post-greffe : comment choisir le meilleur donneur en 2019 ? Recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC)

Valérie Dubois , Kahina Amokrane , Yves Beguin , Benedicte Bruno , Patrice Chevallier et al.
Bulletin du Cancer, 2020, 107 (1), pp.S72-S84. ⟨10.1016/j.bulcan.2019.07.011⟩
Journal articles hal-02887929v1
Image document

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer

Rawand Masoud , Gabriela Reyes-Castellanos , Sophie Lac , Julie Garcia , Samir Dou et al.
Cell Reports Medicine, 2020, 1 (8), pp.100143. ⟨10.1016/j.xcrm.2020.100143⟩
Journal articles hal-03097443v1

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study

Gwenaelle Gravis , Patricia Marino , Daniel Olive , Frederique Penault-Llorca , Jean-Pierre Delord et al.
BMC Cancer, 2023, 23 (1), pp.393. ⟨10.1186/s12885-023-10881-8⟩
Journal articles hal-04109560v1
Image document

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

Anthony Ferrari , Anne Vincent-Salomon , Xavier Pivot , Anne-Sophie Sertier , Emile Thomas et al.
Nature Communications, 2016, 7, pp.Article number: 12222. ⟨10.1038/ncomms12222⟩
Journal articles hal-01388446v1

Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database

Alexandre de Nonneville , Christophe Zemmour , Sophie Frank , Florence Joly , Isabelle Ray-Coquard et al.
Gynecologic Oncology, 2021, ⟨10.1016/j.ygyno.2021.07.019⟩
Journal articles hal-03345277v1

Physical training increases heart rate variability in healthy prepubertal children

S. Mandigout , A. Melin , Laurent Fauchier , L N'Guyen , D. Courteix et al.
European Journal of Clinical Investigation, 2002, 32 (7), pp.479-487. ⟨10.1046/j.1365-2362.2002.01017.x⟩
Journal articles hal-03679787v1

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway

Laura Cheradame , Ida Chiara Guerrera , Julie Gaston , Alain Schmitt , Vincent Jung et al.
Oncogene, 2021, 40 (49), pp.6627-6640. ⟨10.1038/s41388-021-02037-4⟩
Journal articles hal-03874137v1

[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].

Sylvie Lantuejoul , Julien Adam , Nicolas Girard , Mickael Duruisseaux , Audrey Mansuet-Lupo et al.
Annales de Pathologie, 2018, 38 (2), pp.110 - 125. ⟨10.1016/j.annpat.2018.01.007⟩
Journal articles hal-01927078v1

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)

Loïc Lebellec , Bruno Chauffert , Jean-Yves Blay , Axel Le Cesne , Christine Chevreau et al.
European Journal of Cancer, 2017, 79, pp.119 - 128. ⟨10.1016/j.ejca.2017.03.037⟩
Journal articles hal-01655981v1
Image document

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Anne-Claire Mamez , Axelle Dupont , Didier Blaise , Patrice Chevallier , Edouard Forcade et al.
Journal of Hematology and Oncology, 2020, 13 (1), pp.56. ⟨10.1186/s13045-020-00892-4⟩
Journal articles hal-02869718v1

Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders

Julien Rossignol , Amani Ouedrani , Cristina Bulai Livideanu , Stéphane Barete , Louis Terriou et al.
The Journal of Allergy and Clinical Immunology: In Practice, 2022, 10 (5), pp.1356-1364.e2. ⟨10.1016/j.jaip.2021.12.038⟩
Journal articles pasteur-03697054v1
Image document

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound

Rodrigo Tomas-Grau , Florencia González-Lizárraga , Diego Ploper , César Avila , Sergio Socías et al.
Cells, 2022, 11 (17), pp.2759. ⟨10.3390/cells11172759⟩
Journal articles hal-03775634v1

Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database

Audrey Mailliez , Veronique d'Hondt , Amelie Lusque , Olivier Caron , Luc Cabel et al.
International Journal of Cancer, 2022, ⟨10.1002/ijc.34304⟩
Journal articles hal-03868020v1

Defining Benchmark Outcomes for Distal Pancreatectomy: Results of a French Multicentric Study.

Thibault Durin , Ugo Marchese , Alain Sauvanet , Safi Dokmak , Zineb Cherkaoui et al.
Annals of Surgery, 2022, Publish Ahead of Print, ⟨10.1097/SLA.0000000000005539⟩
Journal articles hal-03711172v1

Quels résultats de l’année 2016 vont avoir un impact sur nos pratiques ? Le point de vue du Comité de rédaction du Bulletin du Cancer

Stéphane Vignot , Thierry André , Anthony Gonçalves , Romain Guiéze , Nicolas Magné et al.
Bulletin du Cancer, 2017, 104 (1), pp.6 - 19. ⟨10.1016/j.bulcan.2016.11.009⟩
Journal articles hal-01655990v1
Image document

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel Klionsky , Amal Kamal Abdel-Aziz , Sara Abdelfatah , Mahmoud Abdellatif , Asghar Abdoli et al.
Autophagy, 2021, 17 (1), pp.1-382. ⟨10.1080/15548627.2020.1797280⟩
Journal articles inserm-03285572v1

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

M Duchmann , B Braun , J.B. Micol , P Platzbecker , P. Park et al.
Blood Cancer Journal, 2017, 7 (5), pp.e562. ⟨10.1038/bcj.2017.41⟩
Journal articles hal-01655936v1